Cheung, Alison M.
Wang, Dan
Quintayo, Mary Anne
Yerofeyeva, Yulia
Spears, Melanie
Bartlett, John M. S.
Stein, Lincoln
Bayani, Jane
Yaffe, Martin J.
Funding for this research was provided by:
Ontario Institute for Cancer Research (Adaptive Oncology)
Article History
Received: 13 December 2024
Accepted: 29 April 2025
First Online: 21 May 2025
Declarations
:
: Whole-mount processing of lumpectomy specimens were approved by the Research Ethics Board (REB) at Sunnybrook Health Sciences Centre (Toronto, ON): PIN#192–2009. Need for consent to participate was waived since the research does not involves additional risk to patients. The study of lumpectomy specimens with molecular profiling assays and protein multiplexing were approved by the Sunnybrook REB: PIN#292–2014. Construction of tissue microarray, nucleic acid extraction and molecular profiling performed at the Ontario Institute for Cancer Research (Toronto, ON) was approved under REB#36112.
: Not applicable.
: The authors declare no competing interests.